Blesl A, Petritsch W, Binder L, Furst S, et al. Treatment persistence of ustekinumab and vedolizumab in IBD patients is independent of prior immunogenicity to anti-TNFs: a retrospective study. Scand J Gastroenterol 2022;57:1327-1330.
PMID: 35732583